GLP1R and glaucoma: There is also a concern that the altered metabolic state from rapid weight loss, induced by weight loss injections, like GLP-1 receptor agonists, may affect intraocular pressure regulation, posing a risk for glaucoma in susceptible individuals by increasing IOP, a key factor in glaucoma development [53].